Vox: Critics worried an HIV prevention pill would encourage risky sex. So far, it hasn’t.
“…For Truvada to have a big impact, high-risk populations need to know about it and have access. Research has shown that awareness among men is still pretty low. In some of the developing countries that could most benefit from PrEP, the World Health Organization has noted, adherence to the drug — and its efficacy — were also lower [than in a study published this week in Clinical Infectious Diseases]. In other words, this is no silver bullet or magic pill for problems of health education and access…” (Belluz, 9/3).